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Phenolics based chalcones and indanone derivatives synthesized  on steroidal and non 
steroidal skeletons were tested  for their chemopreventive and radical scavenging action. 
Most of these compounds possessed a 3,4,5- trimethoxyphenyl unit which might be inducing 
enzyme inhibition and scavenging radical formation.  
Further investigations are on the way to establish the structure-activity relationship, so that 
these compounds can be developed as anticancer agents.  
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CANCER STATISTICS 
 Cancer, one of the leading cause of death worldwide, is an abnormal cell proliferation 
that fails to respond to the normal signals.   
 In an effort to eradicate the growing menace of cancer, a clear understanding of 
fundamental biology and molecular mechanism of carcinogenesis is essential for 
targeted therapies.  
 Among the devised strategies being in use for cancer treatment, the one that is of 
immense interest is the development of plant based novel anticancer agents.  
 Due to their tremendous availability, biological activity and efficacy, the 
phytochemicals deemed a gibbous future in chemoprevention. 
 In the present study, several phenolics based structurally related compounds of 
steroidal and non-steroidal skeleton were synthesized and tested for their modulatory 
effect on ornithine decarboxylase activity, an enzyme highly upregulated in cancer.  
 Additionally, these compounds were also examined for radical scavenging action to 
establish a correlation with the anticancer property.  
Class Primary target 
Cyclooxygenase -2 inhibitor Cyclooxygenase -2 
Selective Estrogen Receptor Modulators Estrogen receptor 
5-alpha reductase inhibitor 5-alpha reductase (type -1) 
Ras inhibitor Farnysyl transferase 
Tyrosine kinase inhibitor Tyrosine kinase 
Matrixmetalloproteinase inhibitor Matrixmetalloproteinase 
Polyamines biosynthesis inhibitors Ornithine decarboxylase, Aromatase, 
S-Adenosine decarboxylase 
PPAR-γ agonist PPAR-γ  
RXR selective ligand RARs, RAXs 
Cellular retinol binding protein ligand Cellular retinol binding protein 
AP-1 inhibitors AP-1 
Jun kinase inhibitor Jun kinase 
Cyclin  dependent kinase inhibitors Cyclin dependent kinase 
Monoclonal Abs Her-2,EGFR,VEGF 
Gene therapy p53 
MOLECULAR TARGETS IN CANCER CHEMOPREVENTION 
5,62,340 
5,69,490 
5,71,950 2009 
2010 
2011 
Estimated  deaths 
14,79,350 
15,29,560 
15,96,670 2009 
2010 
2011 
Estimated cases 
Vijaya Dubey1, Nusrat Masood1, Suaib Luqman1* and Arvind S Negi2 
INTRODUCTION 
-5 
0 
5 
10 
15 
20 
25 
30 
35 
40 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 
P
er
ce
n
t 
S
ca
v
en
g
in
g
 
50   µg 10   µg 2 µg 0.4   µg 
Fig 3: DPPH free radical scavenging Assay of NBA(1-14) 
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Fig 2: Ornithine decarboxylase Inhibition of NBA(1-14) 
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Fig 1: Nitric oxide Inhibition Assay of NBA(1-14) 
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